Hongqi Lue

Hongqi Lue

Auto-generated profile, based on publicly available information

Hongqi Lue

Institute of Biochemistry and Molecular Cell Biology Medical School RWTH Aachen University Aachen Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2021 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
GHGuillaume Holzer
Guillaume Holzer
PMPaola De Magistris
Paola De Magistris
CGCathrin Gramminger
Cathrin Gramminger
RSRuchika Sachdev
Ruchika Sachdev
AMAdriana Magalska
Adriana Magalska
Wolfram AntoninWolfram Antonin
Wolfram Antonin
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 January 2016 in Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
JPJulia Pohl
Julia Pohl
UHUlrike Hendgen-Cotta
Ulrike Hendgen-Cotta
Christos RammosChristos Rammos
Christos Rammos
PLPeter Luedike
Peter Luedike
EMElena Mull
Elena Mull
Tienush RassafTienush Rassaf
Tienush Rassaf
S-nitrosation of macrophage migration inhibitory factor (MIF) has been shown to be cytoprotective in myocardial ischaemia/reperfusion (I/R) injury. Since the exact mechanism of action is unknown, we here characterise the cardioprotective effects of targeted intracellular accumulation of MIF in myocardial I/R injury. We used different in vivo, ex vivo and in vitro models of myocardial I/R and hypoxia/reoxyge-nation (H/R) injury to determine MIF levels by immunoblots and ELISA in different phases of reperfusion and reoxygenation, respectively. We discovered a rapid decrease of cardiac MIF that was specific to the early phase of reperfusion. Posttranslational modification of MIF via S-nitrosation – proofed by a modified version of the Biotin Switch Assay – prevented this rapid decrease, leading to a targeted intracellular accumulation of MIF in the early phase of reperfusion. Intracellular MIF accumulation preserved the intracellular ability of MIF to reduce oxidative stress as shown by hydrogen peroxide and aconitase activity measurements. Infarct size measurements by TTC staining showed an overall enhanced cardioprotective effect of this protein by reduction of reperfusion injury. In summary, we have unravelled a novel mechanism of MIF-mediated cardioprotection. Targeted intra-cellular accumulation of MIF by S-nitrosation may offer a novel therapeutic approach in the treatment of myocardial I/R-injury.

29 August 2012 in Acta Crystallographica Section F Structural Biology and Crystallization Communications
Verified
Journal Article
Open access
PDF file
Joel TyndallJoel Tyndall
Joel Tyndall
HLHongqi Lue
Hongqi Lue
MRMalcolm T. Rutledge
Malcolm T. Rutledge
JBJürgen Bernhagen
Jürgen Bernhagen
Mark B. HamptonMark B. Hampton
Mark B. Hampton
SWSigurd M. Wilbanks
Sigurd M. Wilbanks
Macrophage migration inhibitory factor is irreversibly inhibited via covalent modification by phenethyl isothiocyanate, a naturally occurring compound with anti-inflammatory and anticancer properties. The structure of the modified protein obtained from X-ray diffraction data to 1.64 Å resolution is presented. The inhibitor sits within a deep hydrophobic pocket between subunits of the homotrimer and is highly ordered. The secondary structure of macrophage migratory inhibitory factor is unchanged by this modification, but there are significant rearrangements, including of the side-chain position of Tyr37 and the main chain of residues 31-34. These changes may explain the decreased binding of the modified protein to the receptor CD74. Together with the pocket, the areas of conformational change define specific targets for the design of more selective and potent inhibitors as potential therapeutics.